Sign in
4

Changes in Ownership

PHIBRO ANIMAL HEALTH CORP Filed Acc 0001104659-26-012073

President and CEO sold 110,842 shares at an average $48.38 ($5,362,103)

  • President and CEO acquired 185,000 shares (conversion)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENDHEIM JACK · President and CEO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-05 Conversion : show line 1 in the form 10b5-1 +185,000 233,800 I
2026-02-05 Sale : show line 2 in the form 10b5-1 −409 $44.47 $18,188 233,391 I
2026-02-05 Sale : show line 3 in the form 10b5-1 −3,640 $45.42 $165,344 229,751 I
2026-02-05 Sale : show line 4 in the form 10b5-1 −3,171 $46.68 $148,027 226,580 I
2026-02-05 Sale : show line 5 in the form 10b5-1 −38,209 $47.91 $1,830,421 188,371 I
2026-02-05 Sale : show line 6 in the form 10b5-1 −46,275 $48.65 $2,251,418 142,096 I
2026-02-05 Sale : show line 7 in the form 10b5-1 −19,138 $49.57 $948,705 122,958 I
Open-market sales · 110,842 sh · avg $48.38 · $5,362,103

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-05 Conversion : show line 8 in the form 10b5-1 Class B Common Stock −185,000 19,696,034 I
Loading xslF345X05/tm265586-1_4seq1.xml…